Microbiome signatures associated with clinical stages of gastric Cancer: whole metagenome shotgun sequencing study/Experiment 1

From BugSigDB


Needs review

Curated date: 2024/07/17

Curator: Shulamite

Revision editor(s): Shulamite, Aleru Divine

Subjects

Location of subjects
Taiwan
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Gastric cancer Ca body - stomach,ca greater curvature of stomach,Ca lesser curvature - stomach,cancer of stomach,gastric cancer,gastric cancer, intestinal,gastric neoplasm,malignant gastric neoplasm,malignant gastric tumor,malignant neoplasm of body of stomach,malignant neoplasm of lesser curve of stomach,malignant neoplasm of stomach,malignant neoplasm of the stomach,malignant stomach neoplasm,malignant tumor of body of stomach,malignant tumor of greater curve of stomach,malignant tumor of lesser curve of stomach,malignant tumor of stomach,malignant tumor of the stomach,stomach cancer,Gastric cancer
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Chronic gastritis
Group 1 name Corresponds to the case (exposed) group for case-control studies
Gastric Cancer
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Participants diagnosed with early and late stage gastric cancer.
Group 0 sample size Number of subjects in the control (unexposed) group
33
Group 1 sample size Number of subjects in the case (exposed) group
32
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
6 months

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
4.27
Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
age, sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged

Signature 1

Needs review

Curated date: 2024/07/21

Curator: Shulamite

Revision editor(s): Shulamite, Aleru Divine

Source: Figure 2(a)

Description: Comparative analysis of differential abundance between chronic gastritis and gastric cancer at the genus levels using LEfSe.

Abundance in Group 1: increased abundance in Gastric Cancer

NCBI Quality ControlLinks
Coprococcus
Fusobacterium
Haemophilus
Oscillibacter
Parabacteroides
Phascolarctobacterium
Sutterella
Veillonella
unclassified Sutterellaceae

Revision editor(s): Shulamite, Aleru Divine

Signature 2

Needs review

Curated date: 2024/07/21

Curator: Shulamite

Revision editor(s): Shulamite, Aleru Divine

Source: Figure 2(a)

Description: Comparative analysis of differential abundance between chronic gastritis and gastric cancer at the genus levels using LEfSe.

Abundance in Group 1: decreased abundance in Gastric Cancer

NCBI Quality ControlLinks
Bifidobacterium
Collinsella
Pseudomonas
Enterococcus
Adlercreutzia
Acinetobacter

Revision editor(s): Shulamite, Aleru Divine